{
    "title": "114_hr2391",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Medicaid Generic Drug Price Fairness \nAct of 2015''.\n\nSEC. 2. APPLYING THE MEDICAID ADDITIONAL REBATE REQUIREMENT TO GENERIC \n              DRUGS.\n\n    (a) In General.--Section 1927(c)(3) of the Social Security Act (42 \nU.S.C. 1396r-8(c)(3)) is amended--\n            (1) in subparagraph (A), by striking ``The amount'' and \n        inserting ``Except as provided in subparagraph (C), the \n        amount''; and\n            (2) by adding at the end the following new subparagraph:\n                    ``(C) Additional rebate.--\n                            ``(i) In general.--The amount of the rebate \n                        specified in this paragraph for a rebate \n                        period, with respect to each dosage form and \n                        strength of a covered outpatient drug other \n                        than a single source drug or an innovator \n                        multiple source drug, shall be increased in the \n                        manner that the rebate for a dosage form and \n                        strength of a single source drug or an \n                        innovator multiple source drug is increased \n                        under subparagraphs (A) and (D) of paragraph \n                        (2), except as provided in clause (ii).\n                            ``(ii) Special rules for application of \n                        provision.--In applying subparagraphs (A) and \n                        (D) of paragraph (2) under clause (i)--\n                                    ``(I) the reference in subparagraph \n                                (A)(i) of such paragraph to `1990' \n                                shall be deemed a reference to `2014';\n                                    ``(II) subject to clause (iii), the \n                                reference in subparagraph (A)(ii) of \n                                such paragraph to `calendar quarter \n                                beginning July 1, 1990' shall be deemed \n                                a reference to the `calendar quarter in \n                                which the average manufacturer price \n                                for the drug is the lowest during the \n                                12-calendar quarter period ending on \n                                September 30, 2014';\n                                    ``(III) subject to clause (iii), \n                                the reference in subparagraph (A)(ii) \n                                of such paragraph to `September 1990' \n                                shall be deemed a reference to `the \n                                last month of such calendar quarter';\n                                    ``(IV) the references in \n                                subparagraph (D) of such paragraph to \n                                `paragraph (1)(A)(ii)', `this \n                                paragraph', and `December 31, 2009' \n                                shall be deemed references to \n                                `subparagraph (A)', `this \n                                subparagraph', and `December 31, 2014', \n                                respectively; and\n                                    ``(V) any reference in such \n                                paragraph to a `single source drug or \n                                an innovator multiple source drug' \n                                shall be deemed to be a reference to a \n                                drug to which clause (i) applies.\n                            ``(iii) Special rule for certain \n                        noninnovator multiple source drugs.--In \n                        applying paragraph (2)(A)(ii)(II) under clause \n                        (i) with respect to a covered outpatient drug \n                        that is first sold as a drug other than a \n                        single source drug or an innovator multiple \n                        source drug after the date that is 3 years \n                        before the date of the enactment of this \n                        subparagraph, such paragraph shall be applied--\n                                    ``(I) by substituting `the \n                                applicable quarter' for `the calendar \n                                quarter beginning July 1, 1990'; and\n                                    ``(II) by substituting `the last \n                                month in such applicable quarter' for \n                                `September 1990'.\n                            ``(iv) Applicable quarter defined.--In this \n                        subsection, the term `applicable quarter' \n                        means, with respect to a drug described in \n                        clause (iii), the fifth full calendar quarter \n                        in which the drug is sold as a drug other than \n                        a single source drug or an innovator multiple \n                        source drug.''.\n    (b) Effective Date.--The amendments made by subsection (a) shall \napply to rebate periods beginning after December 31, 2014."
}